肺癌、小细胞肺癌、非小细胞肺癌的医学论文

[070] 与肺癌患者的年龄，性别和阶段有关的细胞免疫学参数。

Cellular immunologic parameters related to age, gender, and stage in lung cancer patients.

http://europepmc.org/article/MED/10717331

[071] 抗凝药物可增加肺癌的自然杀伤细胞活性。

Anticoagulant drugs increase natural killer cell activity in lung cancer.

http://europepmc.org/article/MED/15639720

[072] 活化的自然杀伤细胞的细胞毒性和粘附分子在小细胞肺癌中的表达。

Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer.

http://europepmc.org/article/MED/22399608

[073] 非小细胞肺癌-免疫细胞BAK（BRM活化杀手）治疗

Non-small cell lung cancer--immunocell BAK (BRM activated killer) therapy

http://europepmc.org/article/MED/16838654

[074] 肺癌中肿瘤内NK细胞表型和功能的深刻协同变化

Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.

http://europepmc.org/article/MED/21708957

[075] 浸润人类非小细胞肺癌的自然杀伤细胞富含CD56 bright CD16（-）细胞，并显示出杀死肿瘤细胞的能力受损。

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.

http://europepmc.org/article/MED/18203207

ꂃ上一篇：无

ꁹ下一篇：无